Stay updated on Mepolizumab Clinical Trial for HES & Severe Asthma
Sign up to get notified when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.

Latest updates to the Mepolizumab Clinical Trial for HES & Severe Asthma page
- Check2 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA general NIH notice about terminology changes appears above the ClinicalTrials.gov 403 error page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the previous content. A basic header and Home link remain, indicating that the primary study information is no longer accessible on this page.SummaryDifference15%

- Check50 days agoChange DetectedThe page shows a new software revision label, updating from v3.6.6 to v3.7.0 to reflect a deployment of the study record page.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now displays Revision: v3.6.6 instead of v3.6.5, indicating a small update to the page's versioning or template rather than substantive changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Mepolizumab Clinical Trial for HES & Severe Asthma
Enter your email address, and we'll notify you when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.